Office Information:

UNC Chapel Hill
101 Manning Drive
4041 Burnett Womack
Chapel Hill NC 27599
(919) 445-0369


MD, University of Chicago



Research and Publications:

Regenerative Medicine, Pharmacoengineering, Vascular Biology
Vascular biology, nanotechnology, drug delivery, biomedical engineering, materials science, chemistry

Dr. Kibbe’s research interests focus on developing novel therapies for patients with vascular disease while simultaneously studying the mechanism of how these therapies impact the vascular wall. Active projects include developing a novel biodegradable drug-eluting liquid cast stent, developing a new methodology to treat atherosclerosis by reducing plaque burden, investigating the role of resident adventitial progenitor cells in the vasculature, developing and evaluating an endothelial progenitor cell-derived bioengineered ePTFE graft, developing a sustainable drug releasing vascular graft, and developing highly innovative, targeted therapeutics for a variety of vascular disorders including restenosis, atherosclerosis, and hemorrhage. Dr. Kibbe's laboratory currently receives funds from the NIH, DOD, and the VA. Dr. Kibbe has also participated in many clinical trials investigating the efficacy of gene and cell-based therapies for patients with critical limb ischemia as well as therapeutic and exercise-based trials for patients with peripheral arterial disease.